-
-
-
-
-
-
-
Cogent Biosciences Announces Closing of Upsized Public Offering of Shares of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
-
-
-
-
-
-
Form S-3 Cogent Biosciences, Inc.
-
-
-
-
-
-
-
Cogent Biosciences Announces Proposed Public Offering of Common Stock
-
-
-
-
-
-
-
Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2022 Financial Results
-
-
-
-
-
-
-
Form S-3 Cogent Biosciences, Inc.
-
-
-
-
-
-
-
Form S-3 Cogint, Inc.
68,144 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

